AG
GMAB icon

Aperio Group’s Genmab GMAB Stock Holding History

Aperio Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$15.2M Buy
373,099
+28,387
+8% +$1.06M 0.04% 406
2020
Q3 		$12.6M Buy
344,712
+60,069
+21% +$2.17M 0.04% 401
2020
Q2 		$9.65M Buy
284,643
+38,664
+16% +$1.05M 0.04% 470
2020
Q1 		$5.21M Sell
245,979
-4,037
-2% -$90K 0.02% 638
2019
Q4 		$5.58M Buy
250,016
+38,744
+18% +$846K 0.02% 704
2019
Q3 		$4.28M Buy
+211,272
New +$4.16M 0.02% 756

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aperio Group's GMAB Position: Q4 2020 in Review

Aperio Group increased its Genmab (GMAB) stake by 8.2% in Q4 2020, buying an estimated $1.06M and bringing the position to 373,099 shares worth $15.2M. The position accounts for 0.04% of the portfolio, ranked #406.

Aperio Group first reported a position in GMAB in Q3 2019 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2020.

  • Aperio Group held 373,099 shares of Genmab worth $15.2M as of Q4 2020.
  • Aperio Group bought 28,387 Genmab shares in Q4 2020, an estimated $1.06M.
  • Genmab made up 0.04% of Aperio Group's portfolio in Q4 2020, its #406 holding.
  • Aperio Group first reported a position in Genmab in Q3 2019 and has held it in 6 quarters since.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.